1-3 of 3
Alan K. Lichtenstein, M.D.
Close
Sort by
Journal Articles

The Internal Ribosome Entry Site-Medaited Expression of VEGF Rescues HS Sultan Tumor Cells From Mammalian Target of Rapamycin (mTOR)-Inhibitors Induced Apoptosis in Vivo

Patrick Frost, Joseph Gera, Alan K. Lichtenstein, M.D.
Journal: Blood
Blood (2012) 120 (21): 1659.
https://doi.org/10.1182/blood.V120.21.1659.1659
Published: 2012
Journal Articles

Once a Week Bortezomib with Dexamethasone Is Effective with Limited Toxicity in Newly Diagnosed Multiple Myeloma Patients with Older Age and Co-Morbidities,

Nikhil C. Munshi, MD, Saem Lee, B.A., Suman Kambhampati, M.D., Michal Rose, M.D., Abid Mohiuddin, M.D., Yvonne Efebera, M.D., Andrew Han, B.A., Antoun Houranieh, RPh., M.S., Ph.D., Abraham Zimelman, M.D., Mary T. Brophy, M.D., Rao Prabhala, Ph.D., Terrence Grady, DO, PhD, Paulette Mehta, M.D, MPH, Teresa G Hayes, M.D., Sarvari Venkata Yellapragada, MBBS, MD, Caroline Behler, M.D., Catherine Klein, M.D., David Roodman, MD, PhD, Alan K. Lichtenstein, M.D.
Journal: Blood
Blood (2011) 118 (21): 3964.
https://doi.org/10.1182/blood.V118.21.3964.3964
Published: 2011
Journal Articles

Interim Results of An Ongoing Clinical Study Suggests Efficacy and Improved Toxicity Profile with Once a Week Bortezomib with Dexamethasone In Newly Diagnosed Multiple Myeloma Patients with Older Age and Co-Morbidities

Nikhil C. Munshi, M.D., Saem Lee, B.A., Suman Kambhampati, M.D., Abid Mohiuddin, M.D., Michal Rose, M.D., Caroline Behler, M.D., Andrew Han, B.A., Yvonne Efebera, M.D., Antoun Houranieh, RPh., M.S., Ph.D., Mary T. Brophy, M.D., Abraham Zimelman, M.D., Rao H Prabhala, Ph.D., Hussain I. Saba, M.D, Ph.D, Catherine Klein, M.D., Paulette Mehta, M.D, MPH, Teresa Hayes, M.D., David Roodman, M.D, Ph.D, Alan K. Lichtenstein, M.D.
Journal: Blood
Blood (2010) 116 (21): 3061.
https://doi.org/10.1182/blood.V116.21.3061.3061
Published: 2010